4D Molecular Therapeutics, Inc.

FDMT

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001650648

SEC filings (opens in a new tab)

In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding 4D Molecular Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of FDMT: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	80	2	90	+12
Shares	26.1M	43.9K	26.0M	−91.7K (−0.4%)
Value	$395.3M	$664.0K	$181.7M	−$213.0M (−54.0%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to FDMT in Q2 2022
Institution	Shares	Value	% of portfolio
Acadian Asset Management LLC	94,959	$663.0K	0.00%
Jacobs Levy Equity Management, Inc	89,641	$626.0K	0.00%
Trexquant Investment LP	50,780	$354.0K	0.02%
HRT Financial LP	37,461	$261.0K	0.00%
Occudo Quantitative Strategies LP	35,307	$246.0K	0.02%
Peloton Wealth Strategists	30,614	$214.0K	0.10%
Schonfeld Strategic Advisors LLC	29,300	$205.0K	0.00%
Walleye Capital LLC	28,068	$196.0K	0.01%
D. E. Shaw & Co., Inc.	25,670	$179.0K	0.00%
Cubist Systematic Strategies, LLC	23,568	$165.0K	0.00%
Jump Financial, LLC	22,500	$157.0K	0.01%
Cornercap Investment Counsel Inc	21,543	$150.0K	0.03%
Ergoteles LLC	20,600	$144.0K	0.00%
XTX Topco Ltd	19,947	$139.0K	0.06%
Alps Advisors Inc	19,155	$134.0K	0.00%
Man Group plc	–	$121.0K	0.00%
Public Employees Retirement System of Ohio	17,216	$120.0K	0.00%
Point72 Hong Kong Ltd	2,262	$16.0K	0.00%
Quantbot Technologies LP	1,421	$9.00K	0.00%
Simplex Trading, LLC	602	$4.00K	0.00%
TCI Wealth Advisors, Inc.	450	$3.00K	0.00%
Federated Hermes, Inc.	219	$2.00K	0.00%
Captrust Financial Advisors	332	$2.00K	0.00%
Crewe Advisors LLC	142	$1.00K	0.00%

Sold out (12)

Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of FDMT in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Rafferty Asset Management, LLC	71,774	$1.08M
Nisa Investment Advisors, LLC	16,100	$243.0K
Wetherby Asset Management Inc	15,839	$239.0K
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.	13,443	$203.0K
Allspring Global Investments Holdings, LLC	7,806	$118.0K
Virtus ETF Advisers LLC	7,683	$116.0K
Russell Investments Group, Ltd.	742	$11.0K
Atlas Capital Advisors LLC	675	$10.2K
Prospera Financial Services Inc	150	$2.00K
Kayne Anderson Rudnick Investment Management LLC	52	$1.00K
Signaturefd, LLC	45	$1.00K
CWM, LLC	47	$1.00K

Not filed for Q2 2022 yet (2)

Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FDMT in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Parametric Portfolio Associates LLC	40,381	$611.0K
Amalgamated Financial Corp.	3,495	$53.0K